MNOV

MediciNova (MNOV)

About MediciNova (MNOV)

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

Details

Daily high
$1.32
Daily low
$1.29
Price at open
--
52 Week High
$1.96
52 Week Low
$1.17
Market cap
64.0M
Dividend yield
0.00%
Volume
105
Avg. volume
43,909
P/E ratio
-5.45

MediciNova News

Details

Daily high
$1.32
Daily low
$1.29
Price at open
--
52 Week High
$1.96
52 Week Low
$1.17
Market cap
64.0M
Dividend yield
0.00%
Volume
105
Avg. volume
43,909
P/E ratio
-5.45